About this trial
This study is looking at whether vitamin C can help improve oxidative stress and blood vessel health in females after menopause. We will see if taking different amounts of vitamin C for a few days changes how the body handles stress from exercise. This could lead to safer ways to protect females from heart disease without using hormone therapy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Post-menopausal (for females; defined as no menstrual cycle for 1-year)
Sedentary (<150min of moderate-intensity exercise per week or not engaged in a regular exercise program)
Non-smoking
Weight stable (+/-3 kg over the past 3 months)
Disqualifiers
Overt CVD
Any condition or medication contraindicating safe exercise
Hormone replacement therapy (last 3-months)
Use of vasoactive medications (e.g., calcium channel blockers, statins, ACE inhibitors, ARBs, nitrates, alpha-/beta-blockers, diuretics), diabetes, or unstable medication regimens
Trial design
Crossover
Treatments tested in this trial
Vitamin C (Ascorbic Acid)
Dietary supplementSubjects will be supplemented with the following vitamin C doses: 0mg, 200mg, 500mg, 1000mg.
Treatment groups
Trial outcomes
Primary outcomes
Flow-Mediated Dilation (FMD%) - Brachial Artery Endothelial Function
Brachial artery endothelial function will be measured by flow-mediated dilation (FMD) in each participant 5x (at baseline and after 0mg (placebo) 200mg, 500mg, and 1000mg of vitamin C). Participants will be placed in a supine position with their left forearm slightly extended and supinated with legs straight. The brachial artery will be imaged using a high-resolution 7.5MHz linear array transducer at rest, during 5 minutes of forearm occlusion via cuff inflation (250mmHg), and continuously for 2 minutes post-occlusion; an EKG trigger will be used to capture images during end-diastole of the cardiac cycle.
Basal ROS Concentrations - plasma 8-Isoprostane (8-iso) and malondialdehyde (MDA)
A venous blood sample will be collected from a vein in the antecubital fossa. Plasma will be separated out and stored at -80C until concentrations of 8-Isoprostane (8-iso) and malondialdehyde (MDA) are measured via commerically available ELISA kits. ROS concentrations will be measured at 5x points: at baseline and after 0mg (placebo), 200mg, 500mg, and 1000mg of vitamin C
Resting ROS/NO Balance - plasma N-oxides (nitrite and nitrate)
Venous blood samples will be collected from an antecubital fossa vein. Plasma will be separated out and stored at -80C until analysis. Plasma N-oxides (nitrite and nitrate) will be evaluated from the plasma via ozone-based chemiluminescence using a Sievers NOA model 280i. The N-oxides will be compared with the basal ROS also measured to calculate a ROS/NO balance.
Exercise-Induced ROS (plasma 8-Isoprostane (8-iso) and malondialdehyde (MDA)) and NO (plasma nitrate and nitrite)
An intravenous catheter will be placed into a vein in the antecubital fossa. Participants will complete 4 high-intensity exercise sessions (\~200kcals). Each exercise session will be after 3-days of vitamin C supplementation (0mg/placebo, 200mg, 500mg, and 1000mg). Blood will be collected immediately before, immediately after, 15-min after, and 30-min after exercise. Plasma will be separated out and used to evaluate the changes in ROS (plasma 8-Isoprostane (8-iso) and malondialdehyde (MDA)) and NO (plasma nitrate and nitrite) from baseline/rest.
Secondary outcomes
Vitamin C
Blood samples will be collected to evaluate compliance. We will measure vitamin C concentrations after each supplementation phase.
Oral Nitrate Reducing Capacity
Assessment of the oral microbiome's ability to reduce nitrate to nitrite. This will be measured through an unstimulated saliva sample and a rinse of a standard nitrate solution.
Pulse Wave Analysis and Velocity
Brachial artery blood pressures will be obtained using a standard sphygmomanometer. Aortic blood pressures will be obtained using applanation tonometry (SphygmoCor version 8.0, AtCor Medical).
Microvascular Function
Participants will remain in a supine position with their left or right forearm slight extended and supinated. The cuff used for FMD will remain in place and two circular discs will be placed on the participants extended forearm. A laser Doppler imager (Moor Instruments - FLPI2) will be positioned directly over the participants forearm to measure skin blood flow in three different ways: microvascular flow mediated dilation, acetylcholine, and local thermal heating.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: